The 2020 ACC Expert Consensus Decision Pathway provides guidance for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing PCI or with ASCVD.
This is a temporarily removed expert consensus decision pathway regarding antithrombotic therapy in patients with AF/VTE undergoing PCI or with ASCVD.
Tasa de eventos absoluta: 0% vs 0%
This article has been temporarily removed as it was inadvertently posted ahead of an agreed-upon embargo. The article will be reinstated upon embargo expiry. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal .
Kumbhani et al. (Thu,) reported a other. The 2020 ACC Expert Consensus Decision Pathway provides guidance for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing PCI or with ASCVD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: